J
Janneke Wilschut
Researcher at Erasmus University Rotterdam
Publications - 36
Citations - 1678
Janneke Wilschut is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Medicine & Colorectal cancer. The author has an hindex of 15, co-authored 26 publications receiving 1590 citations.
Papers
More filters
Journal ArticleDOI
Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force
Ann G. Zauber,Iris Lansdorp-Vogelaar,Amy B. Knudsen,Janneke Wilschut,Marjolein van Ballegooijen,Karen M. Kuntz +5 more
TL;DR: Two independent microsimulation modeling groups from the Cancer Intervention and Surveillance Modeling Network (CISNET), funded by the National Cancer Institute, used a comparative modeling approach to compare life-years gained relative to resource use of different strategies for colorectal cancer screening.
Journal ArticleDOI
Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels
Lieke Hol,Janneke Wilschut,M. van Ballegooijen,A J van Vuuren,H van der Valk,Jacqueline C. Reijerink,A C M van der Togt,E. J. Kuipers,J. D. F. Habbema,M E van Leerdam +9 more
TL;DR: In conclusion, immunochemical faecal occult blood testing is considerably more effective than gFOBT screening within the range of tested cut-off values and an acceptable trade-off between detection rate and NNscope.
Journal ArticleDOI
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
Janneke Wilschut,Lieke Hol,Evelien Dekker,Jan B.M.J. Jansen,Monique E. van Leerdam,Iris Lansdorp-Vogelaar,Ernst J. Kuipers,J. Dik F. Habbema,Marjolein van Ballegooijen +8 more
TL;DR: FIT screening is more cost-effective at a cutoff level of 50 ng/mL than at higher cutoff levels, which is considerably lower than the values used in current practice.
Journal ArticleDOI
Diagnostic Yield Improves With Collection of 2 Samples in Fecal Immunochemical Test Screening Without Affecting Attendance
Aafke H. van Roon,Janneke Wilschut,Lieke Hol,Marjolein van Ballegooijen,Jacqueline C. Reijerink,Hans 't Mannetje,Laura J.C. Kranenburg,Katharina Biermann,Anneke J van Vuuren,Jan Francke,Alexandra C M van der Togt,Dik J.F. Habbema,Monique E. van Leerdam,Ernst J. Kuipers +13 more
TL;DR: There is no difference in attendance for subjects offered 1- or 2-sample FIT screening, which allows for the development of efficient FIT Screening strategies that can be adapted for local colonoscopy capacities, rather than varying the cut-off value in a 1-sample strategy.
Journal ArticleDOI
Individualizing colonoscopy screening by sex and race.
Iris Lansdorp-Vogelaar,Marjolein van Ballegooijen,Ann G. Zauber,Rob Boer,Janneke Wilschut,Sidney J. Winawer,J. Dik F. Habbema +6 more
TL;DR: The improvements in costs and effects of individualizing CRC screening on a population level were only marginal, and individualized guidelines could contribute to decreasing disparities between blacks and whites.